EPISODE · Feb 26, 2021 · 12 MIN
INVITA – Innovations in plant testing in Australia
from GRDC Podcast · host Grains Research and Development Corporation
Growers are set to get better variety recommendations faster through a new GRDC investment, INVITA, which is adding value to the National Variety Trial (NVT) program. The investment is led by Prof Scott Chapman from the University of Queensland (UQ) which is working in collaboration with Australian partner, CSIRO. The investment, INVITA, leverages off a major EU investment INVITE (Innovations in plant Variety Testing in Europe), a consortium led by INRA in France (INRA being the French equivalent of CSIRO). The main INVITE collaborator with INVITA is Prof Fred van Eeuwijk, a statistician from Wageningen University and Research (WUR), the world's number one agricultural university. Contact: Prof Scott Chapman, University of Queensland [email protected] Useful resources: https://youtu.be/2hOQPRb-z1A Learn more about your ad choices. Visit megaphone.fm/adchoices
What this episode covers
Growers are set to get better variety recommendations faster through a new GRDC investment, INVITA, which is adding value to the National Variety Trial (NVT) program. The investment is led by Prof Scott Chapman from the University of Queensland (UQ) which is working in collaboration with Australian partner, CSIRO. The investment, INVITA, leverages off a major EU investment INVITE (Innovations in plant Variety Testing in Europe), a consortium led by INRA in France (INRA being the French equivalent of CSIRO). The main INVITE collaborator with INVITA is Prof Fred van Eeuwijk, a statistician from Wageningen University and Research (WUR), the world's number one agricultural university. Contact: Prof Scott Chapman, University of Queensland [email protected] Useful resources: https://youtu.be/2hOQPRb-z1A Learn more about your ad choices. Visit megaphone.fm/adchoices
NOW PLAYING
INVITA – Innovations in plant testing in Australia
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m